Pay in 4 interest-free payments of $7.41 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
The most serious event during clinical development was the death of a participant during a trial, which led to the interruption of ConjuChem's clinical program
Huggins, C
PubMed Central, de Luis, Daniel Antonio, Gonzalo Diaz Soto, et al
In this review, we focus on how GLP-1 receptor agonists, insulin and other incretin mimetics exert multiple neuroprotective effects and could provide an effective new therapeutic strategy for neurodegenerative diseases
*Correspondence: Hao Liu, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Pink1, Parkin, DJ-1 and mitochondrial dysfunction in Parkinson's disease
US$ 20.96
US$ 25.76
US$ 27.52
US$ 21.54
US$ 23.65
